The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Search for "giant cell arteritis"

Search results for: giant cell arteritis

Varicella Zoster Virus Not Associated with Giant Cell Arteritis Pathogenesis

February 4, 2020 • By Carina Stanton

Researchers suggest antiviral therapy is not appropriate for patients with GCA, based on their study findings and related research…... [Read More]

Filed Under: Conditions, Vasculitis Tagged With: GCA, giant cell arteritis (GCA), varicella zoster virus

New Insights into the Management of Giant Cell Arteritis

January 28, 2020 • By Lara C. Pullen, PhD

A systematic literature review identified novel evidence on the treatment and management of GCA that was incorporated into the most recent EULAR recommendations on the management of large vessel vasculitis. Investigators confirmed the efficacy of prompt initiation of glucocorticoids and found fast-track approaches to diagnosis lowered the risk of ischemic complications…... [Read More]

Filed Under: Conditions, Vasculitis Tagged With: EULAR, GCA, giant cell arteritis (GCA), guideline, large-vessel vasculitis, recommendations, tocilizumab

Race May Not Be a Risk Factor for Giant Cell Arteritis

October 21, 2019 • By Lara C. Pullen, PhD

Past research has identified being of Northern European descent as a risk factor, among others such as age, sex and HLA DRB1, for developing giant cell arteritis (GCA). But new research casts doubts on this idea, finding that rates of biopsy proven GCA may not differ by race…... [Read More]

Filed Under: Conditions Tagged With: GCA, giant cell arteritis (GCA), race, Risk Factors

Permanent Vision Loss in Late Giant Cell Arteritis

October 18, 2018 • By Kimberly Retzlaff

Patients with polymyalgia rheumatica (PMR) or peripheral arthritis may require extra vigilance during treatment because of a suspected link to giant cell arteritis (GCA) and, potentially, permanent vision loss. “Development of giant cell arteritis after treating polymyalgia or peripheral arthritis: a retrospective case-control study,” a March 2018 study published in The Journal of Rheumatology, suggests… [Read More]

Filed Under: Conditions, Vasculitis Tagged With: peripheral arthritis, polymyalgia rheumatica (PMR), vision loss, visual loss

Trial Data Reveals the Limitations of Steroids in Giant Cell Arteritis Therapy

September 20, 2018 • By Thomas R. Collins

AMSTERDAM—Just how seldom prednisone is successful at inducing remission in giant cell arteritis (GCA), despite such a long history of use for the disease, is one of the many lessons to emerge from the data in the GiACTA trial, said the principal investigator of the trial, which is the largest ever in GCA and is… [Read More]

Filed Under: Conditions, Vasculitis Tagged With: giant cell arteritis (GCA), Steroids, tocilizumab

Exciting Advances in Giant Cell Arteritis Diagnosis & Treatment

May 17, 2018 • By Jason Liebowitz, MD

Baltimore—Rheumatologists and meteor­ologists share more in common than you might suspect, said Dr. Rebecca Manno, assistant professor of medicine for the Division of Rheumatology at Johns Hopkins University, Baltimore, and assistant director of the Johns Hopkins Vasculitis Center. At a March 8 meeting of the Maryland Society for the Rheumatic Diseases, Dr. Manno used the… [Read More]

Filed Under: Vasculitis Tagged With: Giant Cell Arteritis, tocilizumab

Experts Discuss Proposed Giant Cell Arteritis Risk Tool

April 26, 2018 • By Kathy Holliman

A proposed model to predict the risk of giant cell arteritis (GCA) prior to a temporal artery biopsy could help triage patients and guide decision making about the need for biopsy or monitoring (see Figure 1). There’s no specific biomarker for GCA, and GCA can be a “diagnostic conundrum, especially when it presents in an… [Read More]

Filed Under: Vasculitis Tagged With: Giant Cell Arteritis, Vasculitis

Updates on Giant Cell Arteritis

March 19, 2018 • By Susan Bernstein

SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?… [Read More]

Filed Under: Meeting Reports, Vasculitis Tagged With: ACR/ARHP Annual Meeting, giant cell arteritis (GCA)

Abatacept Plus Prednisone Therapy Studied for Treating Giant Cell Arteritis

September 17, 2017 • By Linda Childers

A recent study, conducted by the Vasculitis Clinical Research Consortium and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), examined whether the addition of abatacept, a drug that affects T cell activation, to standard prednisone treatment could reduce the risk of relapse in patients with giant cell arteritis (GCA).1 Although… [Read More]

Filed Under: Conditions, Vasculitis Tagged With: abatacept, ACR Journal Review, American College of Rheumatology, Giant Cell Arteritis, Glucocorticoids, patient care, prednisone, relapse, Research, rheumatology, risk, Steroid, T cell, therapy, Treatment, Vasculitis

Rheumatology Drug Updates: Giant Cell Arteritis Relapse Possible if Tocilizumab Discontinued; Plus Updates on Rituximab, Etanercept

January 19, 2017 • By Michele B. Kaufman, PharmD, BCGP

GCA Relapse Possible When Discontinuing Tocilizumab In a Phase 2 randomized, controlled trial, tocilizumab, an anti-IL-6 biologic agent, was shown to induce and maintain remission for up to 52 weeks in patients with giant cell arteritis (GCA).1 During this trial, patients with GCA were randomized in a 2:1 ratio to receive 8 mg/kg bodyweight tocilizumab… [Read More]

Filed Under: DMARDs & Immunosuppressives, Drug Updates Tagged With: Approval, drug, etanercept, FDA, Giant Cell Arteritis, outcome, patient care, Quality, relapse, Research, rheumatology, rituximab, Safety, trial

  • 1
  • 2
  • 3
  • …
  • 12
  • Next Page »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

This site uses cookies: Find out more.